Literature DB >> 12396231

Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

David W Litchfield1.   

Abstract

Protein kinase CK2 ('casein kinase II') has traditionally been classified as a messenger-independent protein serine/threonine kinase that is typically found in tetrameric complexes consisting of two catalytic (alpha and/or alpha') subunits and two regulatory beta subunits. Accumulated biochemical and genetic evidence indicates that CK2 has a vast array of candidate physiological targets and participates in a complex series of cellular functions, including the maintenance of cell viability. This review summarizes current knowledge of the structural and enzymic features of CK2, and discusses advances that challenge traditional views of this enzyme. For example, the recent demonstrations that individual CK2 subunits exist outside tetrameric complexes and that CK2 displays dual-specificity kinase activity raises new prospects for the precise elucidation of its regulation and cellular functions. This review also discusses a number of the mechanisms that contribute to the regulation of CK2 in cells, and will highlight emerging insights into the role of CK2 in cellular decisions of life and death. In this latter respect, recent evidence suggests that CK2 can exert an anti-apoptotic role by protecting regulatory proteins from caspase-mediated degradation. The mechanistic basis of the observation that CK2 is essential for viability may reside in part in this ability to protect cellular proteins from caspase action. Furthermore, this anti-apoptotic function of CK2 may contribute to its ability to participate in transformation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12396231      PMCID: PMC1223072          DOI: 10.1042/BJ20021469

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  205 in total

1.  GTP plus water mimic ATP in the active site of protein kinase CK2.

Authors:  K Niefind; M Pütter; B Guerra; O G Issinger; D Schomburg
Journal:  Nat Struct Biol       Date:  1999-12

2.  Specific binding of protein kinase CK2 catalytic subunits to tubulin.

Authors:  M Faust; N Schuster; M Montenarh
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

3.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 4.  Casein kinase 2 as a potentially important enzyme in the nervous system.

Authors:  P R Blanquet
Journal:  Prog Neurobiol       Date:  2000-02       Impact factor: 11.685

Review 5.  Nuclear matrix and protein kinase CK2 signaling.

Authors:  K Ahmed
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1999       Impact factor: 1.807

6.  The regulatory beta subunit of protein kinase CK2 mediates formation of tetrameric CK2 complexes.

Authors:  K C Graham; D W Litchfield
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

Review 7.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

8.  Protein kinase CK2: evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles.

Authors:  B Guerra; S Siemer; B Boldyreff; O G Issinger
Journal:  FEBS Lett       Date:  1999-12-03       Impact factor: 4.124

9.  Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle.

Authors:  D Li; G Dobrowolska; L D Aicher; M Chen; J H Wright; P Drueckes; E L Dunphy; E S Munar; E G Krebs
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

10.  Assignment of the human casein kinase II alpha' subunit gene (CSNK2A1) to chromosome 16p13.2-p13.3.

Authors:  T L Yang-Feng; T Naiman; I Kopatz; D Eli; N Dafni; D Canaani
Journal:  Genomics       Date:  1994-01-01       Impact factor: 5.736

View more
  476 in total

1.  Isolation of a CK2α subunit and the holoenzyme from the mussel Mytilus galloprovincialis and construction of the CK2α and CK2β cDNAs.

Authors:  Regina-Maria Kolaiti; Andrea Baier; Ryszard Szyszka; Sophia Kouyanou-Koutsoukou
Journal:  Mar Biotechnol (NY)       Date:  2010-10-05       Impact factor: 3.619

2.  Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension.

Authors:  Zeng-You Ye; De-Pei Li; Li Li; Hui-Lin Pan
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 3.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

Review 4.  Regulation of phospholipid synthesis in the yeast Saccharomyces cerevisiae.

Authors:  George M Carman; Gil-Soo Han
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

5.  Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Authors:  Béatrice Laudet; Caroline Barette; Vincent Dulery; Olivier Renaudet; Pascal Dumy; Alexandra Metz; Renaud Prudent; Alexandre Deshiere; Otto Dideberg; Odile Filhol; Claude Cochet
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

6.  NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.

Authors:  Xiang Li; Bin Guan; Sam Maghami; Charles J Bieberich
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Hao Pan; Andrea Kabosova; Mathias Montenarh; Khalil Ahmed; John S Penn; Candy K Chan; David R Hinton; Maria B Grant; Alexander V Ljubimov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  A comparative study of ATP analogs for phosphorylation-dependent kinase-substrate crosslinking.

Authors:  Satish Garre; Chamara Senevirathne; Mary Kay H Pflum
Journal:  Bioorg Med Chem       Date:  2014-01-30       Impact factor: 3.641

9.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

10.  Synthesis of bone-like nanocomposites using multiphosphorylated peptides.

Authors:  Charles Sfeir; Ping-An Fang; Thottala Jayaraman; Aparna Raman; Zhang Xiaoyuan; Elia Beniash
Journal:  Acta Biomater       Date:  2014-01-13       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.